MedPath

Calibra Medical, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Device: Bolus Insulin Patch (Calibra Finesse)
Device: Insulin Pen (Novo-Nordisk FlexPen®)
First Posted Date
2015-09-07
Last Posted Date
2025-02-04
Lead Sponsor
Calibra Medical, Inc.
Target Recruit Count
278
Registration Number
NCT02542631
Locations
🇺🇸

Encompass Clinical Research, Spring Valley, California, United States

🇺🇸

Physicians Research Associates, Lawrenceville, Georgia, United States

🇩🇪

BAG Unterm Heilig Kreuz Unterm Heilig Kreuz, Fulda, Germany

and more 49 locations

Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections

Phase 2
Completed
Conditions
Diabetes Mellitus
Interventions
Device: Finesse
Device: Pen/Syringe (Usual injection device)
First Posted Date
2010-02-23
Last Posted Date
2025-02-04
Lead Sponsor
Calibra Medical, Inc.
Target Recruit Count
38
Registration Number
NCT01073566
Locations
🇺🇸

California Pacific Medical Center, San Francisco, California, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

🇺🇸

Henry Ford Health System, Detroit, Michigan, United States

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath